Effects of Marijuana On Brain, Body & BehaviorOver 111 million Americans have tried it at least once. An estimated 2.4 million Americans used it for the first time in 2012
View material
Read summary by Corinne Shea
| Nora Volkow Nora D. Volkow, M.D. is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health, US. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the use of brain imaging to investigate the toxic effects and addictive properties of abusable drugs. <… More
|
THE CONVENTIONS AND THE LEGALIZATION OF THE NON-MEDICAL USE OF DRUGSDraft intervention by Mr. Raymond Yans at The 21st ECAD Mayors’ Conference / The 4th World Forum Against Drugs in Stockholm, Sweden, 20 May 2014
View material
| Raymond Yans Raymond Yans was the head of the Drug Unit, Ministry of Foreign Affairs (1995-1999 and 2003-2007); charged with the national coordination of the ratification and implementation process of the Convention on Psychotropic Substances of 1971 and the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (1995-1998). He participated in the launching of t… More
|
Young people in Africa – What our future holds
| Rogers Kasirye Rogers Kasirye, Executive Director, Uganda Youth Development Link, board member WFAD. BA in Social work and Social administration and an MA in Human Rights from Makerere University, Kampala. Mr. Kasirye has undertaken several consultancy positions as a technical Coordinator, he is also a consultant with Mentor foundation UK. He is the local expert advisor to UNODC in Eastern Africa and is actively… More
|
Treatment in and after prisonHow do drug treatment and criminal justice system work together in and after prison? Recovery is more and more becoming the aim of treatment in Europe today. How do we create the broad package of support that results in recovery? View material | Martien Kooyman Martien Kooyman, MD, Ph.D, psychiatrist and psychotherapist. He was the founder and medical director of several therapeutic communities for addiction and also of treatment centres. He has been lecturer at the Department of Preventive and Social Psychiatry of the Erasmus University in Rotterdam. At present he is, amongst others, Member of the Advisory Council for The Minister of Justice on Prison … More
|
From Harm Reduction to Recovery: A Journey in Drug Treatment Policy and PracticeThe challenge of ensuring that drug treatment services are focused on recovery. Recovery is more and more becoming the aim of treatment in Europe today. How do we create the broad package of support that results in recovery? View material | Neil McKeganey Neil McKeganey BA, MSc, Ph.D. is a sociologist and has carried out research in a wide range of topics related to drugs misuse including undertaking work on pre-teen drug use, on the link between drugs and crime, on the effectiveness of drug enforcement activities, on the effectiveness of drug treatment services and on the impact of drugs policy. Neil McKeganey is the founding director of t… More |
U.S International Drug Policy Priorities
| Richard J. Baum Richard Baum has worked since 1997 at the White House Office of National Drug Control Policy (ONDCP) in various positions. He currently serves as Chief of the six-person International Policy Branch within the Office of Supply Reduction. He coordinates multilateral issues for ONDCP with the United Nations and the Organization of American States and works with a wide variety of international NGOs on… More
|
How can NGOs and the private sector be involved in the process?The global community prepares for the United Nations General Assembly Special Session on Drugs in 2016. How can NGOs be involved in the process?
View material
Read summary by Corinne Shea
| Carmen Masias-Claux Currently Executive President of the National Commission for Development and a Drug-Free Life – DEVIDA, governing body for the fight against drugs in Peru. Degree in Psychology, M.D. Family Therapy, Ph.D. in Psychology.Worked at the Information and Education Center for the Prevention of Drug Abuse – CEDRO as Deputy Director and is a founding member of the institution, created in 1986… More |
The road to UNGASS 2016The global community prepares for the United Nations General Assembly Special Session on Drugs in 2016. How can NGOs be involved in the process?
View material
Read summary by Corinne Shea
| Michel Perron Michel Perron was re-appointed Chief Executive Officer (CEO) of the Canadian Centre on Substance Abuse (CCSA) for another five-year term by the Governor in Council of Canada in November 2012. For more than 12 years, Mr. Perron has passionately championed a national and collaborative approach to prevent and address the impacts of substance abuse. Working with all levels of government as… More |
The Drug Situation in the World: Overview from the NGOsHow are governments and NGOs working to solve multidimensional drug problems in different parts of the world? We focus both on the specific regional challenges and their role in a global context.
View material
| José Ángel Prado García Jose Ángel Prado holds an M.D. degree from Universidad Anahuac, with a specialization in General Psychiatry from the Army and Air Force University, Central Military Hospital. He was also a Hubert Humphrey Fellow on Prevention and Treatment of Addictions at the Johns Hopkins University in Baltimore, Maryland, United States. He holds a certificate in the treatment of substance abuse from… More |
Youth in Europe – a Drug Prevention ProgrammeHow are governments and NGOs working to solve multidimensional drug problems in different parts of the world? We focus on both the specific regional challenges and their role in a global context.
View material
| Jón Sigfússon Jón Sigfússon holds a Master of Public Health and Education from the University of Reykjavik, Iceland. Mr. Sigfússon is the current director of Youth in Europe and the Icelandic Centre of Social Research and Analysis (ICSRA), Reykjavik University, Iceland. He has published and lectured extensively “Evidence based policymaking in the field of drug prevention” and “Adolescence Substance Abu… More
|
Page 1 of 4
Malawian marijuana, part of the global problemHow are governments and NGOs working to solve multidimensional drug problems in different parts of the world? We focus both on the specific regional challenges and their role in a global context.
View material
| Nelson Baziwelo Zakeyu is a social worker and activist against the use of marijuana, harmful consumption of alcohol and tobacco smoking. He has vast experience in policy advocacy and implementation as well as in mobilizing people for support and ownership. He has worked as an Executive Director for Drug Fight Malawi since 2006.
|
New Psychoactive Substances: A Global ChallengeNew psychoactive substances are easily available on the market; they are legal in spite of their danger. What can legislation do to keep up?
View material
Read summary by Corinne Shea
| Martin Raithelhuber Martin Raithelhuber is an Illicit Synthetic Drug Expert with the United Nations Office on Drugs and Crime, Laboratory and Scientific Section. He manages the Global Synthetics Monitoring: Analysis, Reporting and Trends (SMART) Programme, which improves the capacity of countries to generate, analyse, report and use information on illicit synthetic drugs including new psychoactive substances. |
The Long Road Drug-Free PakistanHow are governments and NGOs working to solve multidimensional drug problems in different parts of the world? We focus both on the specific regional challenges and their role in a global context.
View material
| Miss Asia Ashraf Director Rehabilitation and Head Psychology Department Sunny Trust International Addiction Treatment & Rehabilitation Centre.Starting as an intern/volunteer with Sunny Trust International (STI) in 2003, Miss Asia have served STI fulltime since January 2004 till present. Responsibilities covered treatment and rehabilitation as well as prevention. She is involved in development and impleme… More |
Drug Background in New ZealandNew psychoactive substances are easily available on the market; they are legal in spite of their danger. What can legislation do to keep up? In order to protect the health of individuals who use NPS, New Zealand has decided to regulate the market. It is now possible to sell these drugs legally in New Zealand – if you prove that they pose no more than a low risk of harm to individuals who use it.
View material
Read summary by Corinne Shea
| Mike Sabin Mike Sabin is a member of parliament for Northland, New Zealand. He is a nationally and internationally-recognized expert and authority on methamphetamine and drug policy. Mr. Sabin is involved with international drug policy as a member of the International Task Force for Strategic Drug Policy and a fellow and associate of numerous international drug free coalitions.He is the author o… More |
Sten Nordin Sten Nordin was born in 1956 in Nyköping, south of Stockholm. He studied Economics and Sociology at Uppsala University, and has held a number of Public Offices since the early 1980’s. Sten Nordin is currently Mayor of the City of Stockholm and holds a position as president of the City Executive Board. Mayor Nordin is also group leader of the Moderate Party in the City of Stockholm, chairman of … More
|
Marijuana and Opioids
| Bertha K. Madras Bertha Madras, Ph.D., Professor of Psychobiology, Department of Psychiatry at Harvard Medical School (faculty since 1986) and Associate Director for Public Education in the Division on Addictions. She served as Deputy Director, Demand Reduction in the White House Office of National Drug Control Policy (ONDCP), following unanimous Senate confirmation (2006-2008). She advocated for a public health a… More
|
Gender perspective in use and abuse of alcohol and other drugsIn what way and how much do we need to streamline treatment and prevention from a gender perspective? Is there a risk that we adapt to stereotypes of how men and women relate to illicit drug use rather than actual behavior?
View material
Read summary by Corinne Shea
| Lotten Sunna Lotten Sunna was one of the founding members of swedish feminist party Feminist initiative in 2005. She was a director on the first three boards and was one of three people writing the original political program for the party. In the 2014 elections she is running for parliament in place number 10 on the list for F! She has formulated politics around alcohol and drug issues throughout her work and … More
|
Who are most at risk from alcohol and drugs- women or men? Are we negligent of the consequences in men?In what way and how much do we need to streamline treatment and prevention from a gender perspective? Is there a risk that we adapt to stereotypes of how men and women relate to illicit drug use rather than actual behavior?
View material
Read summary by Corinne Shea
| Fredrik Spak Associate Professor, MD, PhD and specialist in general psychiatry and social medicine. Spak’s present medical position is in primary health care in Göteborg, Sweden, and his main work is devoted to addiction medicine and prevention of alcohol related problems, both clinically and in research.Spak’s research concerns epidemiology, particularly concerning women’s alcohol problems, i… More |
Latest Research: CannabisNew scientific tools confirm:
| Fred Nyberg Ph.D., Professor, Department of Pharmaceutical Biosciences Division of Biological Research on Drug Dependence at Uppsala University, Sweden Fred Nyberg, PhD, is currently the Head of Uppsala University (UU) Interdisciplinary Center of Addiction (U-FOLD). He is employed as Senior Professor at the Disciplinary Domain of Medicine and Pharmacy, UU. During 1988-1992 he was employed as Professor in Phar… More
|
Persistent Cannabis Users Show Neuropsychological Decline from Childhood to MidlifeProfessor Meier presents the study “Persistent cannabis users show neuropsychological decline from childhood to midlife”, based on results from the Dunedin study.
View material
| Madeline H. Meier Madeline Meier received her doctorate in clinical psychology from the University of Missouri in 2010, and she completed her postdoctoral training at Duke University in 2013. Dr. Meier is now an assistant professor at Arizona State University, where she teaches classes on substance-use disorders and conducts research on the causes, course, and consequences of substance-use disorders. Her current re… More
|
Page 2 of 4
Leave a Reply
You must be logged in to post a comment.